SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-008203
Filing Date
2024-02-28
Accepted
2024-02-28 16:42:45
Documents
34
Period of Report
2024-02-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49178
2 ex99-1.htm EX-99.1 17958
3 ex99-1_001.jpg GRAPHIC 522953
4 ex99-1_002.jpg GRAPHIC 234506
5 ex99-1_003.jpg GRAPHIC 322019
6 ex99-1_004.jpg GRAPHIC 253075
7 ex99-1_005.jpg GRAPHIC 290825
8 ex99-1_006.jpg GRAPHIC 402233
9 ex99-1_007.jpg GRAPHIC 391598
10 ex99-1_008.jpg GRAPHIC 372049
11 ex99-1_009.jpg GRAPHIC 344965
12 ex99-1_010.jpg GRAPHIC 232344
13 ex99-1_011.jpg GRAPHIC 361326
14 ex99-1_012.jpg GRAPHIC 273863
15 ex99-1_013.jpg GRAPHIC 325844
16 ex99-1_014.jpg GRAPHIC 323572
17 ex99-1_015.jpg GRAPHIC 325144
18 ex99-1_016.jpg GRAPHIC 504822
19 ex99-1_017.jpg GRAPHIC 438716
20 ex99-1_018.jpg GRAPHIC 533583
  Complete submission text file 0001493152-24-008203.txt   9179466

Data Files

Seq Description Document Type Size
21 XBRL SCHEMA FILE cldi-20240228.xsd EX-101.SCH 3893
22 XBRL DEFINITION FILE cldi-20240228_def.xml EX-101.DEF 26803
23 XBRL LABEL FILE cldi-20240228_lab.xml EX-101.LAB 37069
24 XBRL PRESENTATION FILE cldi-20240228_pre.xml EX-101.PRE 25427
35 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6170
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40789 | Film No.: 24696257
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)